期刊文献+

人血丙种球蛋白和阿司匹林治疗对川崎病患儿循环内皮祖细胞功能的影响 被引量:12

Effects of intravenous immunoglobulin and aspirin treatment on the functions of circulating endothelial progenitor cells in children with Kawasaki disease
原文传递
导出
摘要 目的研究人血丙种球蛋白(IVIG)和阿司匹林(ASP)治疗对川崎病患儿循环内皮祖细胞功能的影响及其可能的机制。方法抽取10例川崎病患儿IVIG和ASP治疗前及治疗7 d后的外周血,将单个核细胞诱导培养内皮祖细胞。利用MTT法、改良Boyden小室法、细胞培养板贴壁法测定内皮祖细胞的增殖、迁移和贴壁功能。同时测定血浆中肿瘤坏死因子-α(TNF-α)和超敏C反应蛋白(hs-CRP)的浓度。结果 IVIG和ASP治疗7 d后循环内皮祖细胞的功能较治疗前显著提高。IVIG和ASP治疗7 d后血浆中TNF-α和hs-CRP的浓度显著降低。治疗后TNF-α和hs-CRP浓度的降低与内皮祖细胞功能的提高呈显著正相关关系。结论 IVIG和ASP治疗可显著改善川崎病患儿循环内皮祖细胞的功能,其机制可能与TNF-α和hs-CRP的浓度降低有关。 Objective To study the effects of intravenous immunoglobulin(IVIG) and aspirin treatment on the functions of circulating endothelial progenitor cells(EPCs) in children with Kawasaki disease(KD) and possible mechanisms.Methods Blood samples were obtained in 10 children with KD before and 7 days after the treatment by IVIG and aspirin.MTT method,modified Boyden chamber method and cell culture plate adhesion method were used to assess the functions of EPCs,including proliferation,adhension and migration activities.The plasma levels of tumor necrosis factor-α(TNF-α) and high-sensitivity C reactive protein(hs-CRP) were also measured.Results The functions of circulating EPCs 7 days after IVIG and aspirin treatment were significantly improved.IVIG and aspirin treatment significantly reduced plasma TNF-α and hs-CRP concentrations.There was a significant linear regression relationship between the reduced plasma TNF-α and hs-CRP levels and the increased functions of circulating EPCs.Conclusions IVIG and aspirin treatment can improve the functions of circulating EPCs,possibly through reducing plasma concentrations of TNF-α and hs-CRP.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2011年第12期966-969,共4页 Chinese Journal of Contemporary Pediatrics
基金 广东省医学科学基金(No:B2011291)
关键词 川崎病 内皮祖细胞 肿瘤坏死因子-α 超敏C反应蛋白 儿童 Kawasaki disease Endothelial progenitor cell Tumor necrosis factor-α High-sensitivity C reaction protein Child
  • 相关文献

参考文献22

  • 1Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research[ J]. Arch Dis Child, 2002, 86(4) : 286-290.
  • 2Furukawa S, Matsubara T, Ichiyama T. Regulation of proinflammatory cytokine cascade in Kawasaki disease[ J]. Nippon Rinsho, 2008, 66(2) : 258-264.
  • 3Lau AC, Duong TT, Ito S, Wilson GJ, Yeang RS. Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease[J]. Clin Exp Immunol, 2009, 157(2) : 300-309.
  • 4Lau AC, Dunng TT, Ito S, Yeung RS. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease[J]. Arthritis Rheum, 2009, 60(7) : 2131-2141.
  • 5徐明国,门丽娜,王海霞,祖莹,赵春玉,赵霞,蔡华波,孟祥春,王涛.川崎病患儿循环内皮祖细胞功能与血浆超敏C反应蛋白浓度的关系[J].中国当代儿科杂志,2010,12(7):513-517. 被引量:5
  • 6Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea[ J]. Yonsei Med J, 2003, 44 (6) : 1021-1026.
  • 7Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease [ J]. Circulation, 2005, 111 ( 1 ) : 38-43.
  • 8Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL. Kawasaki disease: an overview[J]. Curr Opin Infect Dis, 2008,21 (3) : 263-270.
  • 9Chen J, Huang L, Song M, Yu S, Gao P, Jing J. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells[ J]. J Cardiovasc Pharmacol, 2009, 53(5): 359-367.
  • 10Zhang Y, Herbert BS, Rajashekhar G, Ingram DA, Yoder MC, Clauss M, et al. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-aetivated protein kinase pathway [J]. Faseb J, 2009, 23 (5) : 1358-1365.

二级参考文献19

  • 1谢永林,邓又斌,常青,向慧娟,刘红云.超声评价川崎病后肱动脉内皮功能[J].郧阳医学院学报,2004,23(4):201-204. 被引量:4
  • 2彭茜,吴青,陈昌辉,洪华,张玲英.血清sIL-2RIL-6与hs-CRP水平的测定在川崎病早期诊断中的临床意义[J].中国当代儿科杂志,2006,8(3):208-210. 被引量:15
  • 3Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diagnosis, management, and long-term implications[ J]. Cardiol Rev, 2007, 15(4) :163-169.
  • 4Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease [J]. Eur J Pediatr, 2008, 167(2) :189-196.
  • 5Hibbert B, Olsen S, O'Brien E. Involvement of progenitor cells in vascular repair[ J]. Trends Cardiovasc Med, 2003, 13 (8) :322- 326.
  • 6Wemer N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes[J]. N Engl J Med, 2005, 353(10):999-1007.
  • 7Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells [ J ]. Cardiovasc Res, 2008, 78 ( 3 ) :413-421.
  • 8Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease[J]. Circulation, 2005, 111 ( 1 ) :38-43.
  • 9Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneu- rysms[J]. Nat Genet, 2008, 40(1) :35-42.
  • 10Wu-Wong JR. Endothelial dysfunction and chronic kidney disease : treatment options [ J ]. Curr Opin Investig Drugs, 2008, 9 (9) : 970-982.

共引文献4

同被引文献89

引证文献12

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部